Skip to content
Review Open access

Priorities for breast cancer risk assessment in UK women under age 50: a survey and discrete choice experiment

Aug 2026 · British Journal of Cancer · Vol 135, pp. 1430 - 1438 · 0 citations · 38 references
Medicine

TL;DR

Offering multifactorial BC risk assessments to younger women in primary care, especially the most proactive and broad approaches, would be acceptable and preferred over current practice.

Abstract

National guidelines recommend English women between 30 and 49 years with moderate/high risk of breast cancer (BC) be offered screening and prevention interventions. Identification largely relies on family history-based criteria amongst women self-presenting in primary care. We aimed to understand the preference for different potential risk assessment strategies in this population. A cross-sectional survey including a discrete choice experiment. Risk assessments were defined using six attributes, including initiation strategy, eligibility for a full/detailed risk assessment, components of the risk assessment, including multifactorial risk assessment based on the BOADICEA/CanRisk model, and sensitivity. Coefficients from conditional logistic regression were used to estimate preference for different risk assessment approaches compared to current care. Participants (n = 893) preferred alternative approaches for risk assessments over current care, particularly where all eligible women were proactively invited and more above-average risk women were correctly identified. All but one of 21 risk assessment approaches was preferred, with the most favoured approaches having a probability of being preferred over current care >92%. Education level and ethnicity potentially impacted the strength of participant priorities. Offering multifactorial BC risk assessments to younger women in primary care, especially the most proactive and broad approaches, would be acceptable and preferred over current practice.

Read PDF

Similar papers

Open access Aug 2026

Age Limits of Breast Cancer Screening with Mammography—A Decision-Analytic Benefit–Harm Evaluation to Inform DecisionMaking for the German Context

It is suggested that inviting women aged 45–74 for a mammogram every two years could prevent more breast cancer deaths and modestly extend both life expectancy and quality-adjusted life expectancy with an acceptable trade-off in additional testing, while more extensive screening brings less favorable incremental harm–b...

G. Sroczynski, L. Hallsson, N. Mühlberger et al. · 0 citations
Open access Sep 2026

Fragmented ownership and multilevel barriers to breast MRI screening among high-risk women: A qualitative study informing development of clinical decision support

Background: Women at high risk for breast cancer include those with pathogenic variants in hereditary breast cancer predisposition genes, high-risk benign breast lesions, or a lifetime risk over 20% based on validated models. Supplemental breast MRI screening improves early detection and reduces interval cancers in hig...

Marlee I. Pincus, Cynthia Law, Vicky Ro et al. · 0 citations
Review Sep 2026

Screening strategies for colorectal cancer: adjusting for individual risk factors

ABSTRACT Introduction Colorectal cancer (CRC) is a common cause of cancer-related mortality. While overall incidence has declined, certain populations – particularly younger patients – have experienced a rise. This suggests a more complex risk profile than the dichotomous average vs high risk delineated in guidelines....

Kelsey L. Anderson, Sophie Montgomery, A. Winslow et al. · 0 citations
Open access Oct 2026

Integrating Polygenic Risk Score, Sex, and Family History to Personalize the Initial Screening Age for Colorectal Cancer.

The increase in PRS was associated with elevated risks of both metastatic CRC at diagnosis and CRC-specific mortality, indicating delayed diagnosis in high-PRS individuals and highlighting the potential benefit of earlier screening.

Wen Sun, Di Liu, Dong-Xue Wang et al. · 0 citations
Open access Aug 2026

Performance of general-population breast cancer risk prediction models in an international consortium

Existing BC risk prediction models provided similar risk discrimination across multiple cohorts, although there was overestimation of risk for high-risk individuals, which supports development of a unified risk model for diverse populations that leverages appropriate incidence rates.

K. Brantley, T. Ahearn, E. Norton et al. · 0 citations
Open access Oct 2026

Economic burden of guideline-discordant cervical cancer screening among commercially insured women age 15 to 20 years.

50 Background: Clinical guidelines recommend against cervical cancer screening in average-risk women younger than 21 years. Nonetheless, prior studies suggest that 13.8% of women aged 15 to 20 years still receive potentially unnecessary cervical cancer screening. We sought to estimate the costs of guideline-dis...

Han-Wen Zhang, Navkiran K. Shokar, Anton L. V. Avanceña et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.